glp 1 for cardiovascular The effects of GLP-1 receptor agonists beyond obesity and type 2 diabetes: An anti-atherosclerotic action The Many Cardiovascular Benefits of

There is also an increased risk of a heart attack without atherosclerosis in people with high Lp(a).[ref] Inflammation as a modifying factor: A study looking at hsCRP levels along with Lp(a) levels showed that inflammation may be a modifying factor in increasing the risk of cardiovascular disease with Lp(a) levels between 50-100 mg/dL

As a physician in Obesity Medicine, having managed patients on GLP-1 therapies for over a decade across both the US and India, a few thoughts to gently add

Disclaimer: Compounded medications are not FDA-approved, but are prepared under federal and state compounding guidelines to meet safety standards

A peptide with this breadth of documented activity should not be abandoned because of a manageable and explainable side effect